Pharmacovigilance
Pharmacovigilance is the science and activities related to the detection, assessment, understanding, and prevention of adverse effects or any other drug-related problems. The goal of pharmacovigilance is to improve patient safety and ensure the benefits of a drug outweigh its risks.
History[edit | edit source]
The concept of Pharmacovigilance has been in existence since the 1960s, following the Thalidomide disaster which led to the establishment of the World Health Organization's (WHO) Programme for International Drug Monitoring.
Importance[edit | edit source]
Pharmacovigilance is crucial in the healthcare industry as it aids in the understanding of the safety profile of drugs. It helps in the detection of Adverse Drug Reactions (ADRs), which can be severe and life-threatening. Early detection of ADRs can lead to changes in the drug's usage and dosage, or even its withdrawal from the market.
Methods[edit | edit source]
Pharmacovigilance employs several methods to collect data, including spontaneous reporting, cohort event monitoring, and the use of large databases. The data collected is then analyzed to identify new safety concerns and to confirm or refute suspected risks.
Organizations[edit | edit source]
Several organizations are involved in pharmacovigilance, including the Food and Drug Administration (FDA), the European Medicines Agency (EMA), and the WHO. These organizations work together to ensure the safety of drugs and to protect public health.
Challenges[edit | edit source]
Despite its importance, pharmacovigilance faces several challenges, including under-reporting of ADRs, lack of awareness among healthcare professionals, and the need for more robust and reliable data collection systems.
Future[edit | edit source]
The future of pharmacovigilance lies in the use of advanced technologies such as Artificial Intelligence and Machine Learning to improve data collection and analysis. These technologies can help in the early detection of ADRs and in the prediction of potential safety concerns.
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
